[Methyldopa-induced hepatitis: 3 case reports].
Daghfous
R
R
Centre National de Pharmacovigilance, Tunis.
el Aidli
S
S
Loueslati
M H
MH
Sakka
T
T
Lakhal
M
M
Ben Mami
N
N
Ben Khelifa
H
H
Belkahia
C H
CH
D016907:Adverse Drug Reaction Reporting Systems; D056486:Chemical and Drug Induced Liver Injury / Q000097:blood / Q000150:complications / Q000191:economics / Q000209:etiology* / Q000473:pathology; D002779:Cholestasis / Q000209:etiology; D016527:Drug Costs; D004363:Drug Utilization; D005260:Female; D006801:Humans; D008750:Methyldopa / Q000009:adverse effects*; D008875:Middle Aged
D008750:Methyldopa
Hépatites médicamenteuses à la méthyldopa: à propos de 3 cas.